Worldwide, the sensitivity of CF NBS varies between 86.6 and 97.5% depending primarily on differences in IRT cut-offs and the detection rate of genetic CFTR analysis panels [15, 16]. This evidence concerns the gene CFTR and cystic fibrosis.